HomeBiogas Moves Its Rwanda Project Closer to Singapore's Carbon Market
HomeBiogas received a letter of intent from Rwanda and a preliminary support letter from Singapore for its Rwanda carbon project. The letters improve the path toward a buyer country with a clear carbon-tax framework, while the next steps are final approval, commercial agreements and installation scale.
HomeBiogas received a letter of intent from Rwanda's environmental authority and a preliminary support letter from Singapore's national environmental agency for its Rwanda carbon project. This is more important than another project update because it connects the source country where the carbon credits are generated with a buyer country that has a carbon tax and an economic incentive to purchase international credits. Singapore currently charges a carbon tax of SGD 45 per ton, about USD 35, and the company notes an expected increase to SGD 50-80 per ton. There is still no final approval, no certainty on volume, timing or consideration, and no signed sale agreement. The filing therefore does not prove near-term revenue, but it improves the quality of the route: HomeBiogas is no longer speaking only about generating carbon credits in a source country, but about a process aimed at a defined buying market in Singapore.
The Key Point Is the Link Between Source Country and Buyer Country
Carbon projects do not become revenue just because the company installs systems. The project must be registered, emissions reductions must be verified, credits must be issued, and a buyer must be willing to pay a price that justifies the investment. This is where Article 6.2 of the Paris Agreement comes in, allowing cooperation between countries for the transfer of emissions-reduction outcomes.
In the latest filing, HomeBiogas received principled support from both important sides of the process: Rwanda as the source country and Singapore as the buyer country. The company describes the letters as a significant milestone because they support continued project advancement under the bilateral implementation agreement between the two governments.
This is not final approval. HomeBiogas itself stresses that completion remains subject to registration and final approvals in Rwanda and Singapore. But for project quality, the difference between a project trying to generate credits and a project supported by both regulatory sides is material. Commercial progress becomes more likely when both the source country and the intended buyer country are already inside the process.
Singapore's Carbon Price Creates an Economic Anchor
Singapore's data points matter because they create a price reference. HomeBiogas states that Singapore's carbon tax is currently SGD 45 per ton, about USD 35, and that the tax is expected to rise to SGD 50-80 per ton, about USD 39-62.
Alongside price, the company notes potential demand for international carbon credits of about 2.5 million tons per year from Singapore companies, and a possible additional 1-2.5 million tons per year from the Singapore government. These figures do not guarantee a sale to HomeBiogas, but they explain why this market is more interesting than a generic voluntary market: there is a tax, there is a regulatory need, and there is a government that says it intends to use Article 6 mechanisms to meet climate targets.
The risk is that a theoretical carbon-tax reference is not HomeBiogas' transaction price. The actual price will be set in commercial agreements that have not yet been signed, depending on credit type, verification quality, delivery timing, commitment size, and project-development and installation costs. The Singapore anchor improves the route, but it does not replace a sale contract.
Installations Are Both the Source of Credits and a Cash Use
HomeBiogas says it is working to sign commercial agreements to commercialize carbon credits or finance project development, aiming to increase the Rwanda installation base to tens of thousands of systems over the coming years. That sentence connects regulatory progress to financial statements.
A system that has not been installed does not generate emissions reductions. Emissions reductions that have not been verified do not become carbon credits. Credits that have not been sold do not become cash. The revenue route therefore has three different stages: installations, verification and credit issuance, and then sale or financing with a customer. The latest filing mostly advances the regulatory and early commercial path, not the cash stage.
The company already shows accumulated activity in the field. In June it reported passing 10,000 installed systems in its carbon projects, and in May it reported a fourth carbon-credit issuance in Kenya and delivery of credits worth about NIS 700 thousand. In Ghana, it received a permanent approval for a project that may issue up to about 1.12 million tons of carbon. The Rwanda-Singapore filing joins that sequence, but it still needs to become large-scale installations and sale agreements.
The Next Filing Needs to Move From Letter to Agreement
HomeBiogas moved closer to a higher-quality sales route because Singapore is a market with a clear economic incentive to purchase carbon credits. That is different from a route based only on general environmental potential. The letters received do not provide certainty on quantity, price, timing or consideration.
The next event that can change the read would be a commercial agreement to commercialize credits, a financing agreement for the Rwanda project, final regulatory approval, or an installation update showing the company can grow the system base at a pace relevant to the Singapore opportunity. Until then, the filing improves the route's probability but does not remove the main question for HomeBiogas: how quickly carbon credits become revenue and cash.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.